Compare XZO & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XZO | ENOV |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Fluid Controls |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2021 | 2008 |
| Metric | XZO | ENOV |
|---|---|---|
| Price | $15.78 | $18.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $27.00 | ★ $47.38 |
| AVG Volume (30 Days) | 195.0K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $216,980,000.00 | N/A |
| Revenue This Year | $9.11 | $6.36 |
| Revenue Next Year | $16.05 | $5.31 |
| P/E Ratio | $33.33 | ★ N/A |
| Revenue Growth | ★ 61.99 | N/A |
| 52 Week Low | $12.36 | $18.52 |
| 52 Week High | $24.60 | $34.28 |
| Indicator | XZO | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 30.35 |
| Support Level | $14.72 | N/A |
| Resistance Level | $17.43 | $27.20 |
| Average True Range (ATR) | 0.65 | 1.27 |
| MACD | -0.11 | -0.62 |
| Stochastic Oscillator | 8.89 | 3.33 |
Exzeo Group Inc provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform, which it refers to as the Exzeo Platform, currently includes nine configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. Through the Exzeo Platform, the company provides technology-based solutions and services for all operational and administrative activities and functions needed by P&C insurance carriers and their agents.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.